HEADER PROTEIN FIBRIL 28-JUN-16 5KNZ TITLE HUMAN ISLET AMYLOID POLYPEPTIDE SEGMENT 19-SGNNFGAILSS-29 WITH EARLY TITLE 2 ONSET S20G MUTATION DETERMINED BY MICROED COMPND MOL_ID: 1; COMPND 2 MOLECULE: HIAPP(RESIDUES 19-29)S20G; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: AMYLIN, DIABETES-ASSOCIATED PEPTIDE, DAP, INSULINOMA AMYLOID COMPND 5 PEPTIDE; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 OTHER_DETAILS: ISLET AMYLOID SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 4 ORGANISM_COMMON: HUMAN; SOURCE 5 ORGANISM_TAXID: 9606 KEYWDS AMYLOID, ISLET AMYLOID POLYPEPTIDE, TYPE II DIABETES, TOXIC SPINE, KEYWDS 2 MICROED, PROTEIN FIBRIL EXPDTA ELECTRON CRYSTALLOGRAPHY AUTHOR P.A.L.KROTEE,J.A.RODRIGUEZ,M.R.SAWAYA,D.CASCIO,D.SHI,B.L.NANNENGA, AUTHOR 2 J.HATTNE,F.E.REYES,T.GONEN,D.S.EISENBERG REVDAT 8 06-MAR-24 5KNZ 1 REMARK REVDAT 7 30-JUN-21 5KNZ 1 REMARK REVDAT 6 20-NOV-19 5KNZ 1 REMARK REVDAT 5 04-SEP-19 5KNZ 1 JRNL REVDAT 4 06-JUN-18 5KNZ 1 REMARK REVDAT 3 25-APR-18 5KNZ 1 REMARK REVDAT 2 13-SEP-17 5KNZ 1 REMARK REVDAT 1 21-DEC-16 5KNZ 0 JRNL AUTH P.KROTEE,J.A.RODRIGUEZ,M.R.SAWAYA,D.CASCIO,F.E.REYES,D.SHI, JRNL AUTH 2 J.HATTNE,B.L.NANNENGA,M.E.OSKARSSON,S.PHILIPP,S.GRINER, JRNL AUTH 3 L.JIANG,C.G.GLABE,G.T.WESTERMARK,T.GONEN,D.S.EISENBERG JRNL TITL ATOMIC STRUCTURES OF FIBRILLAR SEGMENTS OF HIAPP SUGGEST JRNL TITL 2 TIGHTLY MATED BETA-SHEETS ARE IMPORTANT FOR CYTOTOXICITY. JRNL REF ELIFE V. 6 2017 JRNL REFN ESSN 2050-084X JRNL PMID 28045370 JRNL DOI 10.7554/ELIFE.19273 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 1.90 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.490 REMARK 3 COMPLETENESS FOR RANGE (%) : 83.0 REMARK 3 NUMBER OF REFLECTIONS : 546 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.232 REMARK 3 R VALUE (WORKING SET) : 0.228 REMARK 3 FREE R VALUE : 0.275 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.710 REMARK 3 FREE R VALUE TEST SET COUNT : 53 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 14.6087 - 1.9016 0.83 493 53 0.2275 0.2749 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.130 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 18.570 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.55 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 14.51 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.010 75 REMARK 3 ANGLE : 1.233 100 REMARK 3 CHIRALITY : 0.037 11 REMARK 3 PLANARITY : 0.004 14 REMARK 3 DIHEDRAL : 10.079 24 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5KNZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-JUN-16. REMARK 100 THE DEPOSITION ID IS D_1000222490. REMARK 240 REMARK 240 EXPERIMENTAL DETAILS REMARK 240 RECONSTRUCTION METHOD : CRYSTALLOGRAPHY REMARK 240 SAMPLE TYPE : 3D ARRAY REMARK 240 SPECIMEN TYPE : NULL REMARK 240 DATA ACQUISITION REMARK 240 DATE OF DATA COLLECTION : 11-NOV-14 REMARK 240 TEMPERATURE (KELVIN) : 100.0 REMARK 240 PH : 7.40 REMARK 240 NUMBER OF CRYSTALS USED : NULL REMARK 240 MICROSCOPE MODEL : FEI TECNAI 20 REMARK 240 DETECTOR TYPE : TVIPS TEMCAM-F416 (4K X 4K) REMARK 240 ACCELERATION VOLTAGE (KV) : 200 REMARK 240 NUMBER OF UNIQUE REFLECTIONS : 548 REMARK 240 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 240 RESOLUTION RANGE LOW (A) : 35.400 REMARK 240 DATA SCALING SOFTWARE : XSCALE REMARK 240 COMPLETENESS FOR RANGE (%) : 82.9 REMARK 240 DATA REDUNDANCY : NULL REMARK 240 IN THE HIGHEST RESOLUTION SHELL REMARK 240 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) :1.90 REMARK 240 HIGHEST RESOLUTION SHELL, RANGE LOW (A) :2.13 REMARK 240 COMPLETENESS FOR SHELL (%) : 64.6 REMARK 240 DATA REDUNDANCY IN SHELL : NULL REMARK 240 R MERGE FOR SHELL (I) : 0.15000 REMARK 240 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 240 SOFTWARE USED : PHASER 2.5.6 REMARK 240 STARTING MODEL : NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 2.39000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 35.40000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 9.30000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 35.40000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 2.39000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 9.30000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL UNIT IS AN EXTENDED PAIR OF BETA SHEETS REMARK 300 COMPRISING PEPTIDES AT POSITIONS X,Y,Z AND 1/2+X,-1/2-Y,-Z REPEATED REMARK 300 AD INFINITUM ALONG THE A CRYSTAL AXIS. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: OCTADECAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 -19.12000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 3 1.000000 0.000000 0.000000 -14.34000 REMARK 350 BIOMT2 3 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 4 1.000000 0.000000 0.000000 -9.56000 REMARK 350 BIOMT2 4 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 4 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 5 1.000000 0.000000 0.000000 -4.78000 REMARK 350 BIOMT2 5 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 5 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 6 1.000000 0.000000 0.000000 4.78000 REMARK 350 BIOMT2 6 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 6 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 7 1.000000 0.000000 0.000000 9.56000 REMARK 350 BIOMT2 7 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 7 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 8 1.000000 0.000000 0.000000 14.34000 REMARK 350 BIOMT2 8 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 8 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 9 1.000000 0.000000 0.000000 19.12000 REMARK 350 BIOMT2 9 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 9 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 10 1.000000 0.000000 0.000000 -16.73000 REMARK 350 BIOMT2 10 0.000000 -1.000000 0.000000 9.30000 REMARK 350 BIOMT3 10 0.000000 0.000000 -1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 11 1.000000 0.000000 0.000000 -11.95000 REMARK 350 BIOMT2 11 0.000000 -1.000000 0.000000 9.30000 REMARK 350 BIOMT3 11 0.000000 0.000000 -1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 12 1.000000 0.000000 0.000000 -7.17000 REMARK 350 BIOMT2 12 0.000000 -1.000000 0.000000 9.30000 REMARK 350 BIOMT3 12 0.000000 0.000000 -1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 13 1.000000 0.000000 0.000000 -2.39000 REMARK 350 BIOMT2 13 0.000000 -1.000000 0.000000 9.30000 REMARK 350 BIOMT3 13 0.000000 0.000000 -1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 14 1.000000 0.000000 0.000000 2.39000 REMARK 350 BIOMT2 14 0.000000 -1.000000 0.000000 9.30000 REMARK 350 BIOMT3 14 0.000000 0.000000 -1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 15 1.000000 0.000000 0.000000 7.17000 REMARK 350 BIOMT2 15 0.000000 -1.000000 0.000000 9.30000 REMARK 350 BIOMT3 15 0.000000 0.000000 -1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 16 1.000000 0.000000 0.000000 11.95000 REMARK 350 BIOMT2 16 0.000000 -1.000000 0.000000 9.30000 REMARK 350 BIOMT3 16 0.000000 0.000000 -1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 17 1.000000 0.000000 0.000000 16.73000 REMARK 350 BIOMT2 17 0.000000 -1.000000 0.000000 9.30000 REMARK 350 BIOMT3 17 0.000000 0.000000 -1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 18 1.000000 0.000000 0.000000 21.51000 REMARK 350 BIOMT2 18 0.000000 -1.000000 0.000000 9.30000 REMARK 350 BIOMT3 18 0.000000 0.000000 -1.000000 0.00000 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-8272 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-8273 RELATED DB: EMDB REMARK 900 RELATED ID: 5KO0 RELATED DB: PDB DBREF 5KNZ A 19 29 UNP P10997 IAPP_HUMAN 52 62 SEQADV 5KNZ GLY A 20 UNP P10997 SER 53 ENGINEERED MUTATION SEQRES 1 A 11 SER GLY ASN ASN PHE GLY ALA ILE LEU SER SER FORMUL 2 HOH *(H2 O) CRYST1 4.780 18.600 70.800 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.209205 0.000000 0.000000 0.00000 SCALE2 0.000000 0.053763 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014124 0.00000 ATOM 1 N SER A 19 1.475 -5.572 19.109 1.00 28.39 N ATOM 2 CA SER A 19 0.470 -5.214 18.113 1.00 35.80 C ATOM 3 C SER A 19 0.583 -6.142 16.928 1.00 31.76 C ATOM 4 O SER A 19 1.488 -6.969 16.860 1.00 43.03 O ATOM 5 CB SER A 19 0.626 -3.759 17.640 1.00 37.79 C ATOM 6 OG SER A 19 1.850 -3.572 16.939 1.00 36.17 O ATOM 7 N GLY A 20 -0.319 -5.974 15.973 1.00 33.71 N ATOM 8 CA GLY A 20 -0.378 -6.875 14.842 1.00 30.09 C ATOM 9 C GLY A 20 0.234 -6.359 13.556 1.00 18.66 C ATOM 10 O GLY A 20 1.452 -6.273 13.417 1.00 17.52 O ATOM 11 N ASN A 21 -0.635 -6.031 12.609 1.00 18.61 N ATOM 12 CA ASN A 21 -0.234 -5.700 11.247 1.00 14.04 C ATOM 13 C ASN A 21 -0.752 -4.352 10.850 1.00 10.06 C ATOM 14 O ASN A 21 -1.938 -4.097 10.997 1.00 8.67 O ATOM 15 CB ASN A 21 -0.785 -6.724 10.256 1.00 15.22 C ATOM 16 CG ASN A 21 -0.090 -8.036 10.311 1.00 6.90 C ATOM 17 OD1 ASN A 21 1.088 -8.143 10.671 1.00 10.07 O ATOM 18 ND2 ASN A 21 -0.824 -9.062 9.973 1.00 10.00 N ATOM 19 N ASN A 22 0.121 -3.490 10.342 1.00 13.20 N ATOM 20 CA ASN A 22 -0.351 -2.262 9.722 1.00 17.95 C ATOM 21 C ASN A 22 0.149 -2.204 8.300 1.00 16.58 C ATOM 22 O ASN A 22 1.347 -2.317 8.047 1.00 12.67 O ATOM 23 CB ASN A 22 0.096 -1.024 10.478 1.00 12.56 C ATOM 24 CG ASN A 22 -0.659 0.209 10.050 1.00 19.27 C ATOM 25 OD1 ASN A 22 -1.583 0.659 10.734 1.00 22.95 O ATOM 26 ND2 ASN A 22 -0.265 0.777 8.915 1.00 19.42 N ATOM 27 N PHE A 23 -0.779 -2.030 7.372 1.00 8.96 N ATOM 28 CA PHE A 23 -0.468 -2.220 5.977 1.00 8.99 C ATOM 29 C PHE A 23 -0.946 -1.060 5.133 1.00 4.05 C ATOM 30 O PHE A 23 -2.111 -0.671 5.211 1.00 7.92 O ATOM 31 CB PHE A 23 -1.093 -3.517 5.482 1.00 9.15 C ATOM 32 CG PHE A 23 -0.791 -3.820 4.052 1.00 8.67 C ATOM 33 CD1 PHE A 23 0.168 -4.779 3.734 1.00 11.83 C ATOM 34 CD2 PHE A 23 -1.486 -3.184 3.026 1.00 6.52 C ATOM 35 CE1 PHE A 23 0.448 -5.077 2.423 1.00 11.17 C ATOM 36 CE2 PHE A 23 -1.209 -3.455 1.710 1.00 6.38 C ATOM 37 CZ PHE A 23 -0.236 -4.404 1.404 1.00 12.99 C ATOM 38 N GLY A 24 -0.050 -0.537 4.309 1.00 4.66 N ATOM 39 CA GLY A 24 -0.395 0.521 3.380 1.00 6.27 C ATOM 40 C GLY A 24 0.315 0.315 2.063 1.00 2.60 C ATOM 41 O GLY A 24 1.537 0.201 2.030 1.00 3.99 O ATOM 42 N ALA A 25 -0.441 0.274 0.975 1.00 0.79 N ATOM 43 CA ALA A 25 0.144 0.150 -0.354 1.00 3.34 C ATOM 44 C ALA A 25 -0.539 1.071 -1.348 1.00 2.84 C ATOM 45 O ALA A 25 -1.757 1.266 -1.317 1.00 5.25 O ATOM 46 CB ALA A 25 0.066 -1.298 -0.854 1.00 6.33 C ATOM 47 N ILE A 26 0.249 1.627 -2.244 1.00 2.12 N ATOM 48 CA ILE A 26 -0.290 2.490 -3.275 1.00 5.67 C ATOM 49 C ILE A 26 0.303 2.044 -4.584 1.00 4.77 C ATOM 50 O ILE A 26 1.526 1.988 -4.734 1.00 6.01 O ATOM 51 CB ILE A 26 0.040 3.971 -3.040 1.00 2.95 C ATOM 52 CG1 ILE A 26 -0.513 4.435 -1.693 1.00 2.59 C ATOM 53 CG2 ILE A 26 -0.584 4.777 -4.138 1.00 5.20 C ATOM 54 CD1 ILE A 26 -0.135 5.865 -1.293 1.00 3.43 C ATOM 55 N LEU A 27 -0.566 1.689 -5.518 1.00 6.46 N ATOM 56 CA LEU A 27 -0.130 1.228 -6.819 1.00 9.41 C ATOM 57 C LEU A 27 -0.649 2.179 -7.892 1.00 9.21 C ATOM 58 O LEU A 27 -1.851 2.382 -8.030 1.00 12.20 O ATOM 59 CB LEU A 27 -0.618 -0.190 -7.091 1.00 6.66 C ATOM 60 CG LEU A 27 0.124 -1.411 -6.514 1.00 14.63 C ATOM 61 CD1 LEU A 27 0.241 -1.399 -4.985 1.00 11.54 C ATOM 62 CD2 LEU A 27 -0.549 -2.697 -6.965 1.00 7.19 C ATOM 63 N SER A 28 0.260 2.755 -8.661 1.00 11.00 N ATOM 64 CA SER A 28 -0.150 3.615 -9.747 1.00 17.43 C ATOM 65 C SER A 28 0.385 3.124 -11.085 1.00 24.09 C ATOM 66 O SER A 28 1.569 3.277 -11.394 1.00 18.92 O ATOM 67 CB SER A 28 0.310 5.056 -9.498 1.00 25.17 C ATOM 68 OG SER A 28 1.723 5.153 -9.490 1.00 23.70 O ATOM 69 N SER A 29 -0.505 2.530 -11.874 1.00 24.21 N ATOM 70 CA SER A 29 -0.195 2.210 -13.264 1.00 28.69 C ATOM 71 C SER A 29 -0.819 3.285 -14.130 1.00 32.58 C ATOM 72 O SER A 29 -1.973 3.667 -13.912 1.00 27.27 O ATOM 73 CB SER A 29 -0.703 0.813 -13.658 1.00 25.19 C ATOM 74 OG SER A 29 -2.114 0.722 -13.560 1.00 18.19 O ATOM 75 OXT SER A 29 -0.174 3.810 -15.037 1.00 35.17 O TER 76 SER A 29 HETATM 77 O HOH A 101 -2.685 1.613 5.964 1.00 7.44 O MASTER 235 0 0 0 0 0 0 6 76 1 0 1 END